894. Patient and Surgery Characteristics on Wound Complication and Surgical Site Infection in Sarcoma Patients undergoing Hemipelvectomy

por Katzman, Ju Hee, Sun, Steven, Joyce, David, Greene, John
Publicado 2020

Evaluation of Lorlatinib Cerebrospinal Fluid Concentrations in Relation to Target Concentrations for Anaplastic Lymphoma Kinase (ALK) Inhibition

por Sun, Steven, Pithavala, Yazdi K., Martini, Jean‐François, Chen, Joseph
Publicado 2022

The Association Between Patient Satisfaction and Patient-Reported Health Outcomes

por Chen, Qinyu, Beal, Eliza W, Okunrintemi, Victor, Cerier, Emily, Paredes, Anghela, Sun, Steven, Olsen, Griffin, Pawlik, Timothy M
Publicado 2018

PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer

por Hartley, Antja-Voy, Wang, Benlian, Mundade, Rasika, Jiang, Guanglong, Sun, Mengyao, Wei, Han, Sun, Steven, Liu, Yunlong, Lu, Tao
Publicado 2020

Using VBIM Technique to Discover ARMC4/ODAD2 as a Novel Negative Regulator of NF-κB and a New Tumor Suppressor in Colorectal Cancer

por Martin, Matthew, Mundade, Rasika, Hartley, Antja-Voy, Jiang, Guanglong, Jin, Jiamin, Sun, Steven, Safa, Ahmad, Sandusky, George, Liu, Yunlong, Lu, Tao
Publicado 2022

Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer

por Hartley, Antja-Voy, Wang, Benlian, Jiang, Guanglong, Wei, Han, Sun, Mengyao, Prabhu, Lakshmi, Martin, Matthew, Safa, Ahmad, Sun, Steven, Liu, Yunlong, Lu, Tao
Publicado 2020

Surface Photovoltage-Induced Ultralow Work Function Material for Thermionic Energy Converters

por Schindler, Peter, Riley, Daniel C., Bargatin, Igor, Sahasrabuddhe, Kunal, Schwede, Jared W., Sun, Steven, Pianetta, Piero, Shen, Zhi-Xun, Howe, Roger T., Melosh, Nicholas A.
Publicado 2019

Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial

por Johnson, Peter W. M., Balasubramanian, Sriram, Hodkinson, Brendan, Shreeve, S. Martin, Sun, Steven, Srinivasan, Srimathi, Steele, Andrew J., Vermeulen, Jessica, Sehn, Laurie H., Wilson, Wyndham H.
Publicado 2023

Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial

por Balasubramanian, Sriram, Hodkinson, Brendan, Schuster, Stephen J., Fowler, Nathan H., Trotman, Judith, Hess, Georg, Cheson, Bruce D., Schaffer, Michael, Sun, Steven, Deshpande, Sanjay, Vermeulen, Jessica, Salles, Gilles, Gopal, Ajay K.
Publicado 2021

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs

por Balogh, Erin P., Bindman, Andrew B., Eckhardt, S. Gail, Halabi, Susan, Harvey, R. Donald, Jaiyesimi, Ishmael, Miksad, Rebecca, Moses, Harold L., Nass, Sharyl J., Schilsky, Richard L., Sun, Steven, Torrente, Josephine M., Warren, Katherine E.
Publicado 2019

Early M‐Protein Dynamics Predicts Progression‐Free Survival in Patients With Relapsed/Refractory Multiple Myeloma

por Yan, Xiaoyu, Xu, Xu Steven, Weisel, Katja C., Mateos, Maria‐Victoria, Sonneveld, Pieter, Dimopoulos, Meletios A., Usmani, Saad Zafar, Bahlis, Nizar J., Puchalski, Thomas, Ukropec, Jon, Bellew, Kevin, Ming, Qi, Sun, Steven, Zhou, Honghui
Publicado 2020

Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell ly...

por Zhu, Jun, Hong, Xiaonan, Song, Yu Qin, Hodkinson, Brendan, Balasubramanian, Sriram, Wang, Songbai, Zhang, Qingyuan, Shi, Yuankai, Huang, Huiqiang, Zhang, Huilai, Zhu, Yan, Shreeve, Stephen Martin, Sun, Steven, Wang, Ze, Wang, Xiaocan, Fan, Yue, Wilson, Wyndham, Vermeulen, Jessica
Publicado 2022

Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation

por Suarez-Kelly, Lorena P., Sun, Steven H., Ren, Casey, Rampersaud, Isaac V., Albertson, David, Duggan, Megan C., Noel, Tiffany C., Courtney, Nicholas, Buteyn, Nathaniel J., Moritz, Charles, Yu, Lianbo, Yildiz, Vedat O., Butchar, Jonathan P., Tridandapani, Susheela, Rampersaud, Arfaan A., Carson, William E.
Publicado 2021

Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma

por Sun, Steven H., Benner, Brooke, Savardekar, Himanshu, Lapurga, Gabriella, Good, Logan, Abood, David, Nagle, Erin, Duggan, Megan, Stiff, Andrew, DiVincenzo, Mallory J., Suarez-Kelly, Lorena P., Campbell, Amanda, Yu, Lianbo, Wesolowski, Robert, Howard, Harrison, Shah, Hiral, Kendra, Kari, Carson, William E.
Publicado 2021

Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial

por Burke, G. A. Amos, Vinti, Luciana, Kabickova, Edita, Beishuizen, Auke, Tacyildiz, Nurdan, Uyttebroeck, Anne, Kang, Hyoung Jin, Luisi, Flavio, Minard-Colin, Véronique, Burkhardt, Birgit, Tamegnon, Monelle, Sun, Steven, Curtis, Madeliene, Deshpande, Sanjay, Nottage, Kerri, Howes, Angela, Srinivasan, Srimathi, Bhojwani, Deepa, Norris, Robin, Cairo, Mitchell
Publicado 2022

Breakpoint Analysis of Transcriptional and Genomic Profiles Uncovers Novel Gene Fusions Spanning Multiple Human Cancer Types

por Giacomini, Craig P., Sun, Steven, Varma, Sushama, Shain, A. Hunter, Giacomini, Marilyn M., Balagtas, Jay, Sweeney, Robert T., Lai, Everett, Del Vecchio, Catherine A., Forster, Andrew D., Clarke, Nicole, Montgomery, Kelli D., Zhu, Shirley, Wong, Albert J., van de Rijn, Matt, West, Robert B., Pollack, Jonathan R.
Publicado 2013

Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study

por Huang, Xiaojun, Qiu, Lugui, Jin, Jie, Zhou, Daobin, Chen, Xiequn, Hou, Ming, Hu, Jianda, Hu, Yu, Ke, Xiaoyan, Li, Junmin, Liang, Yingmin, Liu, Ting, Lv, Yue, Ren, Hanyun, Sun, Aining, Wang, Jianmin, Zhao, Chunting, Salman, Mariya, Sun, Steven, Howes, Angela, Wang, Jingzhao, Wu, Peng, Li, Jianyong
Publicado 2018

Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR

por Avet-Loiseau, Hervé, San-Miguel, Jesus, Casneuf, Tineke, Iida, Shinsuke, Lonial, Sagar, Usmani, Saad Z., Spencer, Andrew, Moreau, Philippe, Plesner, Torben, Weisel, Katja, Ukropec, Jon, Chiu, Christopher, Trivedi, Sonali, Amin, Himal, Krevvata, Maria, Ramaswami, Priya, Qin, Xiang, Qi, Mia, Sun, Steven, Qi, Ming, Kobos, Rachel, Bahlis, Nizar J.
Publicado 2021

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic...

por Fraser, Graeme A.M., Chanan-Khan, Asher, Demirkan, Fatih, Santucci Silva, Rodrigo, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Pavlovsky, Miguel A., Goy, Andre, Mato, Anthony, Hallek, Michael, Salman, Mariya, Tamegnon, Monelle, Sun, Steven, Connor, Anne, Nottage, Kerri, Schuier, Natasha, Balasubramanian, Sriram, Howes, Angela, Cramer, Paula
Publicado 2020

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

por San-Miguel, Jesus, Avet-Loiseau, Hervé, Paiva, Bruno, Kumar, Shaji, Dimopoulos, Meletios A., Facon, Thierry, Mateos, María-Victoria, Touzeau, Cyrille, Jakubowiak, Andrzej, Usmani, Saad Z., Cook, Gordon, Cavo, Michele, Quach, Hang, Ukropec, Jon, Ramaswami, Priya, Pei, Huiling, Qi, Mia, Sun, Steven, Wang, Jianping, Krevvata, Maria, DeAngelis, Nikki, Heuck, Christoph, Van Rampelbergh, Rian, Kudva, Anupa, Kobos, Rachel, Qi, Ming, Bahlis, Nizar J.
Publicado 2022